Detalles de la búsqueda
1.
Archival single-cell genomics reveals persistent subclones during DCIS progression.
Cell
; 186(18): 3968-3982.e15, 2023 08 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-37586362
2.
Treatment Outcomes in Patients With Metastatic Renal Cell Carcinoma With Sarcomatoid and/or Rhabdoid Dedifferentiation After Progression on Immune Checkpoint Therapy.
Oncologist
; 2023 Nov 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-38035767
3.
Nivolumab for the Treatment of Patients with Metastatic Non-Clear Cell Renal Cell Carcinoma (nccRCC): A Single-Institutional Experience and Literature Meta-Analysis.
Oncologist
; 25(3): 252-258, 2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-32162795
4.
Clonal expansion of CD8 T cells in the systemic circulation precedes development of ipilimumab-induced toxicities.
Proc Natl Acad Sci U S A
; 113(42): 11919-11924, 2016 10 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-27698113
5.
Ligand-directed targeting of lymphatic vessels uncovers mechanistic insights in melanoma metastasis.
Proc Natl Acad Sci U S A
; 112(8): 2521-6, 2015 Feb 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-25659743
6.
Interleukin-11 Receptor Is a Candidate Target for Ligand-Directed Therapy in Lung Cancer: Analysis of Clinical Samples and BMTP-11 Preclinical Activity.
Am J Pathol
; 186(8): 2162-2170, 2016 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-27317903
7.
The combination of serum insulin, osteopontin, and hepatocyte growth factor predicts time to castration-resistant progression in androgen dependent metastatic prostate cancer- an exploratory study.
BMC Cancer
; 16: 721, 2016 09 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-27599544
8.
Hypertension and Circulating Cytokines and Angiogenic Factors in Patients With Advanced Non-Clear Cell Renal Cell Carcinoma Treated With Sunitinib: Results From a Phase II Trial.
Oncologist
; 20(10): 1140-8, 2015 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-26306901
9.
A Modular Trial of Androgen Signaling Inhibitor Combinations Testing a Risk-Adapted Strategy in Patients with Metastatic Castration-Resistant Prostate Cancer.
Clin Cancer Res
; 2024 Apr 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-38683200
10.
Targeting neuropilin-1 in human leukemia and lymphoma.
Blood
; 117(3): 920-7, 2011 Jan 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-21063027
11.
Prognostic or predictive plasma cytokines and angiogenic factors for patients treated with pazopanib for metastatic renal-cell cancer: a retrospective analysis of phase 2 and phase 3 trials.
Lancet Oncol
; 13(8): 827-37, 2012 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-22759480
12.
Cytoreductive Nephrectomy for Patients with Metastatic Sarcomatoid and/or Rhabdoid Renal Cell Carcinoma Treated with Immune Checkpoint Therapy.
Eur Urol Focus
; 9(5): 734-741, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-36863962
13.
Phase II trial of neoadjuvant sitravatinib plus nivolumab in patients undergoing nephrectomy for locally advanced clear cell renal cell carcinoma.
Nat Commun
; 14(1): 2684, 2023 05 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37164948
14.
Addition of Metastasis-Directed Therapy to Intermittent Hormone Therapy for Oligometastatic Prostate Cancer: The EXTEND Phase 2 Randomized Clinical Trial.
JAMA Oncol
; 9(6): 825-834, 2023 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37022702
15.
Cell State and Cell Type: Deconvoluting Circulating Tumor Cell Populations in Liquid Biopsies by Multi-Omics.
Cancers (Basel)
; 15(15)2023 Aug 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-37568766
16.
Circulating biomarkers in advanced renal cell carcinoma: clinical applications.
Curr Oncol Rep
; 14(3): 221-9, 2012 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-22434312
17.
Identification of epithelial and mesenchymal circulating tumor cells in clonal lineage of an aggressive prostate cancer case.
NPJ Precis Oncol
; 6(1): 41, 2022 Jun 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-35729213
18.
Predictive Genomic Biomarkers of Hormonal Therapy Versus Chemotherapy Benefit in Metastatic Castration-resistant Prostate Cancer.
Eur Urol
; 81(1): 37-47, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-34716049
19.
Genomic Biomarkers and Genome-Wide Loss-of-Heterozygosity Scores in Metastatic Prostate Cancer Following Progression on Androgen-Targeting Therapies.
JCO Precis Oncol
; 6: e2200195, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35820087
20.
Androgen receptor-negative human prostate cancer cells induce osteogenesis in mice through FGF9-mediated mechanisms.
J Clin Invest
; 118(8): 2697-710, 2008 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-18618013